Fsm Wealth Advisors, LLC Astrazeneca PLC Transaction History
Fsm Wealth Advisors, LLC
- $603 Million
- Q2 2025
A detailed history of Fsm Wealth Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Fsm Wealth Advisors, LLC holds 6,897 shares of AZN stock, worth $510,860. This represents 0.08% of its overall portfolio holdings.
Number of Shares
6,897
Previous 7,119
3.12%
Holding current value
$510,860
Previous $523,000
8.03%
% of portfolio
0.08%
Previous 0.12%
Shares
11 transactions
Others Institutions Holding AZN
# of Institutions
1,422Shares Held
509MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.23 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.05 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.64 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.36 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.32 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $230B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...